Radiation Oncology

Radiation oncology is a medical specialty that uses radiation therapy to treat cancer. The radiation therapy channel covers all aspects of radiation oncology technology. Radiation therapy includes linear accelerators (LINAC), proton therapy, brachytherapy, image guided radiation therapy (IGRT), focused ultrasound, stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), treatment planning systems and tomotherapy.

A new study by Rashi Mehta--a researcher with the WVU School of Medicine and Rockefeller Neuroscience Institute--finds that focused ultrasound may induce an immunological healing effect in the brains of Alzheimer's patients.

A new study by Rashi Mehta--a researcher with the WVU School of Medicine and Rockefeller Neuroscience Institute--finds that focused ultrasound may induce an immunological healing effect in the brains of Alzheimer's patients. Image courtesy of Caylie Silveria/West Virginia University

News | Focused Ultrasound Therapy | March 02, 2021
New Radiology Research Shows Promising Results for Focused Ultrasound Treatment of Alzheimer's
March 2, 2021 — West Virginia University scientists used magnetic resonance imaging (MRI) scans to show what happens...
read more
“Distinction in Stereotactic Radiotherapy” offers comprehensive accreditation program for SRS/SBRT clinical practice and physics quality assurance

Image courtesy of Elekta

News | Stereotactic Body Radiation Therapy (SBRT) | February 26, 2021
The Radiosurgery Society Announces Launch of Joint Accreditation Program with The American College of Radiation Oncology
February 26, 2021 — The Radiosurgery Society (RSS), a non-profit medical society dedicated to advancing the science and...
read more
AiCure, an AI and data analytics company focused on improving clinical trials, and OncoBay Clinical, a full-service boutique contract research organization (CRO) specializing in the simplification of complex oncology programs, today announced a strategic partnership to provide oncology sponsors with scalable, AI-powered insights to improve patient care and optimize drug development.
News | Artificial Intelligence | February 25, 2021
AiCure and OncoBay Clinical Partner to Improve Oncology Clinical Trials and Patient Care
February 25, 2021 —  AiCure, an AI and data analytics company focused on improving clinical trials, and OncoBay...
read more
F-18 FES PET images of patients with ER+/PR+/HER2- invasive ductal carcinoma. Left panel: Progressive disease seen at the 8-week time-point in a patient on sequential therapy. Right panel: Stable disease through all 3 time-points, remaining on study therapy for 6.7 months until disease progression on combined vorinostat aromatase inhibitor therapy. Image created by Lanell M Peterson, Research Scientist, University of Washington Medical Oncology, Seattle WA.

F-18 FES PET images of patients with ER+/PR+/HER2- invasive ductal carcinoma. Left panel: Progressive disease seen at the 8-week time-point in a patient on sequential therapy. Right panel: Stable disease through all 3 time-points, remaining on study therapy for 6.7 months until disease progression on combined vorinostat aromatase inhibitor therapy. Image created by Lanell M Peterson, Research Scientist, University of Washington Medical Oncology, Seattle WA.

News | Molecular Imaging | February 22, 2021
Molecular Imaging Determines Effectiveness of Novel Metastatic Breast Cancer Treatment
February 22, 2021 — Molecular imaging can successfully predict response to a novel treatment for ER-positive, HER2-...
read more
Radiology, radiation therapy, PACS, Enterprise image, X-ray, DR Systems, CT, MRI, contrast, ultrasound, VNA, product comparisons, comparison charts on ITN magazine.
Feature | February 17, 2021
Radiology Product Comparison Charts Aid in Buying Decisions
Imaging Technology News (ITN) maintains more than 40 comparison charts of product specifications from various vendors,...
read more
Insightec plans to expand in Latin America through a partnership with Strattner
News | Focused Ultrasound Therapy | February 16, 2021
MR-Guided Focused Ultrasound To Treat Essential Tremor And Tremor-Dominant Parkinson's Disease
February 16, 2021 — Insightec, a global healthcare company focused on creating the next generation of patient care,...
read more
Immunotherapy-based precision medicine clinical trials being developed

Getty Images

News | Prostate Cancer | February 16, 2021
Why Black Men's Prostate Cancer May be More Responsive to Immunotherapy
February 16, 2021 — Black men die more often of prostate cancer yet, paradoxically, have greater survival benefits from...
read more
The Milton and Caroll Petrie Department of Urology at Mount Sinai has received a $3.8 million donation from philanthropist Robert F. Smith to launch the Robert F. Smith Mobile MRI Unit in partnership with the Mount Sinai Health System to support prostate health in the Black community.

Getty Images

News | Prostate Cancer | February 12, 2021
Mount Sinai Receives $3.8 Million Gift to Launch Mobile MRI Unit to Support Prostate Health in the Black Community
February 12, 2021 — The Milton and Caroll Petrie Department of Urology at Mount Sinai has received a $3.8 million...
read more
ZAP Surgical Systems, Inc. announced 18 new system orders in 2020 for its recently commercialized ZAP-X Gyroscopic Radiosurgery platform.
News | Stereotactic Body Radiation Therapy (SBRT) | February 12, 2021
ZAP Surgical Builds Market for its Novel ZAP-X Gyroscopic Radiosurgery Platform
February 12, 2021 — ZAP Surgical Systems, Inc. announced 18 new system orders in 2020 for its recently commercialized...
read more
Phase III clinical trial of men with a clinical suspicion of prostate cancer finds MRI with targeted biopsies to be more accurate at diagnosis and less intrusive than current standard
News | Magnetic Resonance Imaging (MRI) | February 08, 2021
Using MRI for Prostate Cancer Diagnosis Equals or Beats Current Standard
February 8, 2021 — The results of a Phase III randomized clinical trial have shown that when it comes to detecting...
read more

Chart courtesy of the American Cancer Society

News | Breast Imaging | February 08, 2021
Female Breast Cancer Surpasses Lung as the Most Commonly Diagnosed Cancer Worldwide
February 8, 2021 — Cancer ranks as a leading cause of death in every country in the world, and, for the first time,...
read more

Images in 69-year-old man with biopsy-confirmed Gleason score 7 (3+4) prostate cancer. (a) Pretreatment axial T2-weighted fast spin-echo MRI scan (repetition time msec/echo time msec, 3820/97) shows tumor in midline anterior transition zone (arrow). (b) Intraoperative MRI scan shows contoured rectal wall (red line), prostate margin (blue outline), and region of interest (orange outline). Because the urethra was included in planned treatment volume, a suprapubic catheter was placed for continuous bladder drainage during treatment. (c) Intraoperative MRI scan shows focused ultrasound beam path (blue) overlaid on treatment plan. Rectangles illustrate each sonication spot. (d) Thermal map image obtained during treatment with heat deposition color coded in red overlaid on sonication spot. (e) Axial gadopentetate dimeglumine-enhanced MRI scan (230/2.97) obtained immediately after treatment shows devascularized ablated volume (arrows). (f) Corresponding T2-weighted fast spin-echo MRI scan (3820/97) at 5 months after ablation shows complete involution of transition zone. All seven cores from treatment area margins were negative for cancer at biopsy. Image courtesy of the Radiological Society of North America

News | Prostate Cancer | February 05, 2021
Ultrasound Technique Treats Prostate Cancer with Minimal Side Effects
February 5, 2021 — A technique that delivers high-intensity focused ultrasound to targeted tissue under MRI guidance...
read more
Real Time Imaging Technologies LLC iannounced that it has received U.S. Patent No. 10,898,070 IMAGING APPARATUS AND METHODS which covers the company’s methods for incorporating microlens into X-ray imaging detectors that enables significantly lower radiation dose without compromising image resolution.

Getty Images

News | Radiation Dose Management | February 05, 2021
New Imaging Intellectual Property for Lower Radiation Dose
February 5, 2021 — Real Time Imaging Technologies LLC has received U.S. Patent No. 10,898,070 IMAGING APPARATUS AND...
read more
 GenesisCare — one of the leading oncology providers in the United States, Australia, Spain, and the United Kingdom — announced the addition of a game-changing adaptive therapy, the Ethos.
News | Radiation Therapy | February 04, 2021
GenesisCare Brings Florida Cancer Patients First-of-its-Kind Ethos Adaptive Intelligence Technology
February 4, 2021 —  GenesisCare — one of the leading oncology providers in the United States, Australia, Spain, and the...
read more
Bright spots indicate that cancer cells have responded to a one-day challenge with estrogen in this positron emission tomography (PET) scan of a woman with breast cancer. In a small study, researchers at Washington University School of Medicine in St. Louis found that only women whose tumors responded to estrogen challenge benefited from hormone therapy. The findings could help doctors choose the treatments most likely to help their patients. Image courtesy of Farrokh Dehdashti

Bright spots indicate that cancer cells have responded to a one-day challenge with estrogen in this positron emission tomography (PET) scan of a woman with breast cancer. In a small study, researchers at Washington University School of Medicine in St. Louis found that only women whose tumors responded to estrogen challenge benefited from hormone therapy. The findings could help doctors choose the treatments most likely to help their patients. Image courtesy of Farrokh Dehdashti

News | PET Imaging | February 03, 2021
Imaging Identifies Breast Cancer Patients Unlikely to Benefit from Hormone Therapy
February 3, 2021 — Hormone therapy commonly is given as a targeted treatment for women whose cancer cells carry...
read more
Ludwig Chicago Co-director Ralph Weichselbaum and Kaiting Yang, a postdoctoral researcher in Weichselbaum's lab.

Ludwig Chicago Co-director Ralph Weichselbaum and Kaiting Yang, a postdoctoral researcher in Weichselbaum's lab. Image courtesy of Ludwig Cancer Research

News | Radiation Therapy | January 28, 2021
Ludwig Cancer Research Study Reveals How Certain Gut Bacteria Compromise Radiotherapy
January 28, 2021 — A study led by Ludwig Chicago Co-director Ralph Weichselbaum, M.D., and Yang-Xin Fu, M.D., Ph.D., of...
read more
Aquilion Exceed LB CT System offers industry’s largest bore and widest field-of-view
News | Computed Tomography (CT) | January 25, 2021
Canon Medical’s AI-Powered, Premium Large Bore CT Receives FDA Clearance
Janaury 25, 2021 —Canon Medical Systems USA, Inc. has received FDA clearance for the Aquilion Exceed LB CT system,...
read more
An additional external-beam radiation dose delivered directly to the tumor can benefit the prospects of men with non-metastatic prostate cancer, without causing additional side effects. The risk of relapse within five years for these men is smaller than for men who did not receive this boost, as shown by a large-scale study initiated by UMC Utrecht in collaboration with the Netherlands Cancer Institute, UZ Leuven and Radboudumc.
News | Prostate Cancer | January 25, 2021
Radiation Boost Lowers Risk of Prostate Cancer Recurrence
January 25, 2021 — An additional external-beam radiation dose delivered directly to the tumor can benefit the prospects...
read more
MRI Targeted biopsy is performed using cognitive fusion more easily with anatomical guidance based on the radiology report. MRI targets can be identified quickly in real-time along with micro-ultrasound targets, which may have been missed on MRI.

MRI Targeted biopsy is performed using cognitive fusion more easily with anatomical guidance based on the radiology report. MRI targets can be identified quickly in real-time along with micro-ultrasound targets, which may have been missed on MRI. Image courtesy of Exact Imaging

Feature | Prostate Cancer | January 20, 2021 | By Brian Wodlinger, Ph.D.
Detecting Prostate Cancer With Advanced Micro-ultrasound
Historically when a patient had an elevated PSA (prostate specific antigen) test their urologist would take the next...
read more
The exceptionally high dose rate of the FLASH Beam is 3,000 times higher than normal therapy treatment (300 Gray per second vs. 0.1 Gray per second, Gray being a standard unit measuring absorbed radiation). Instead of treatment over 20 seconds, an entire treatment is completed in 6 milliseconds, giving the therapy its nickname, "FLASH." Image courtesy of Brian Pogue, PhD

The exceptionally high dose rate of the FLASH Beam is 3,000 times higher than normal therapy treatment (300 Gray per second vs. 0.1 Gray per second, Gray being a standard unit measuring absorbed radiation). Instead of treatment over 20 seconds, an entire treatment is completed in 6 milliseconds, giving the therapy its nickname, "FLASH." Image courtesy of Brian Pogue, PhD

News | Linear Accelerators | January 20, 2021
Dartmouth Researchers Pilot FLASH Radiotherapy Beam Development for Treatment of Cancer
January 20, 2021 — A joint team of researchers from Radiation Oncology at Dartmouth's and Dartmouth-Hitchcock's Norris...
read more
© Copyright Wainscot Media. All Rights Reserved.